Digestive Diseases and Sciences

, Volume 63, Issue 10, pp 2703–2713 | Cite as

Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA

  • Peiqi Wang
  • Jun Hu
  • Shadi Ghadermarzi
  • Ali Raza
  • Douglas O’Connell
  • Amy Xiao
  • Faraz Ayyaz
  • Min Zhi
  • Yuanqi Zhang
  • Nimisha K. Parekh
  • Mark Lazarev
  • Alyssa Parian
  • Steven R. Brant
  • Marshall Bedine
  • Brindusa Truta
  • Pinjin Hu
  • Rupa Banerjee
  • Susan M. HutflessEmail author
Original Article



Cigarette smoking is thought to increase the risk of Crohn’s disease (CD) and exacerbate the disease course, with opposite roles in ulcerative colitis (UC). However, these findings are from Western populations, and the association between smoking and inflammatory bowel disease (IBD) has not been well studied in Asia.


We aimed to compare the prevalence of smoking at diagnosis between IBD cases and controls recruited in China, India, and the USA, and to investigate the impact of smoking on disease outcomes.


We recruited IBD cases and controls between 2014 and 2018. All participants completed a questionnaire about demographic characteristics, environmental risk factors and IBD history.


We recruited 337 participants from China, 194 from India, and 645 from the USA. In China, CD cases were less likely than controls to be current smokers (adjusted odds ratio [95% CI] 0.4 [0.2–0.9]). There was no association between current or former smoking and CD in the USA. In China and the USA, UC cases were more likely to be former smokers than controls (China 14.6 [3.3–64.8]; USA 1.8 [1.0–3.3]). In India, both CD and UC had similar current smoking status to controls at diagnosis. Current smoking at diagnosis was significantly associated with greater use of immunosuppressants (4.4 [1.1–18.1]) in CD cases in China.


We found heterogeneity in the associations of smoking and IBD risk and outcomes between China, India, and the USA. Further study with more adequate sample size and more uniform definition of smoking status is warranted.


Smoking Crohn’s disease Ulcerative colitis Asia Environment 



We acknowledge Part of the recruitment for the study included was done via ResearchMatch, a national health volunteer registry that was created by several academic institutions and supported by the United States National Institutes of Health as part of the Clinical Translational Science Award (CTSA) program. ResearchMatch has a large population of volunteers who have consented to be contacted by researchers about health studies for which they may be eligible. We also acknowledge Girish Ganesh and Kavitha Medaboina for their help in recruiting participants at Asian Institute of Gastroenterology in Hyderabad, India. We acknowledge the grant support from Sun Yat-sen University Clinical Research 5010 Program (2014008), Ludwig-Bayless Science Award, and the Johns Hopkins Institute for Clinical and Translational Research (ICTR) which is funded in part by Grant Number UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH.

Compliance with ethical standards

Conflict of interest

No authors have conflict of interest with relation to this study.


  1. 1.
    Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.CrossRefPubMedGoogle Scholar
  3. 3.
    Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42; quiz e30.CrossRefPubMedGoogle Scholar
  4. 4.
    Fung WP, Monteiro EH, Murugasu JJ, Ng KC, Kho KM, Lee SK. Non-specific ulcerative colitis in Chinese and Indians in Singapore. Med J Aust. 1971;2:361–365.PubMedGoogle Scholar
  5. 5.
    Lee SK. Crohn’s disease in Singapore. Med J Aust. 1974;1:266–269.PubMedGoogle Scholar
  6. 6.
    Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646–651.CrossRefPubMedGoogle Scholar
  7. 7.
    Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30:1–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.CrossRefPubMedGoogle Scholar
  9. 9.
    Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.CrossRefPubMedGoogle Scholar
  10. 10.
    Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.CrossRefPubMedGoogle Scholar
  11. 11.
    Brant SR, Wang MH, Rawsthorne P, et al. A population-based case-control study of CARD15 and other risk factors in Crohn’s disease and ulcerative colitis. Am J Gastroenterol. 2007;102:313–323.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology. 1989;96:1016–1020.CrossRefPubMedGoogle Scholar
  14. 14.
    Weterman IT, Pena AS. Familial incidence of Crohn’s disease in The Netherlands and a review of the literature. Gastroenterology. 1984;86:449–452.PubMedGoogle Scholar
  15. 15.
    Wang PQ, Hu J, Al Kazzi ES, et al. Family history and disease outcomes in patients with Crohn’s disease: a comparison between China and the United States. World J Gastrointest Pharmacol Ther. 2016;7:556–563.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. Inflamm Bowel Dis. 2013;19:423–428.CrossRefPubMedGoogle Scholar
  17. 17.
    Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165.e152.CrossRefPubMedGoogle Scholar
  18. 18.
    Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217.CrossRefPubMedGoogle Scholar
  19. 19.
    Mayberry J. A review of environmental factors and Crohn’s disease. Tijdschrift voor gastro-enterologie. 1978;21:267–271.PubMedGoogle Scholar
  20. 20.
    Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clinical research ed.). 1982;284:706.CrossRefGoogle Scholar
  21. 21.
    National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.Google Scholar
  22. 22.
    Harris PA, Scott KW, Lebo L, Hassan N, Lightner C, Pulley J. ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med. 2012;87:66–73.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.CrossRefPubMedGoogle Scholar
  24. 24.
    Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071.CrossRefPubMedGoogle Scholar
  25. 25.
    Niu J, Miao J, Tang Y, et al. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case-control study. PLoS ONE. 2016;11:e0153524.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Moon CM, Park DI, Kim ER, et al. Clinical features and predictors of clinical outcomes in Korean patients with Crohn’s disease: a Korean association for the study of intestinal diseases multicenter study. J Gastroenterol Hepatol. 2014;29:74–82.CrossRefPubMedGoogle Scholar
  27. 27.
    Reif S, Lavy A, Keter D, et al. Lack of association between smoking and Crohn’s disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol. 2000;95:474–478.CrossRefPubMedGoogle Scholar
  28. 28.
    Reif S, Klein I, Arber N, Gilat T. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology. 1995;108:1683–1687.CrossRefPubMedGoogle Scholar
  29. 29.
    Eliakim R, Reif S, Lavy A, et al. Passive smoking in patients with inflammatory bowel disease: an Israeli multicentre case-control study. Eur J Gastroenterol Hepatol. 2000;12:975–979.CrossRefPubMedGoogle Scholar
  30. 30.
    Ng SC, Zeng Z, Niewiadomski O, et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology. 2016;150:86–95.e83; quiz e13-84.CrossRefPubMedGoogle Scholar
  31. 31.
    Arora U, Ananthakrishnan AN, Kedia S, et al. Effect of oral tobacco use and smoking on outcomes of Crohn’s disease in India. J Gastroenterol Hepatol. 2018;33:134–140.CrossRefPubMedGoogle Scholar
  32. 32.
    Sato Y, Matsui T, Yano Y, et al. Long-term course of Crohn’s disease in Japan: incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol. 2015;30:1713–1719.CrossRefPubMedGoogle Scholar
  33. 33.
    Kuenzig ME, Lee SM, Eksteen B, et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016;16:143.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology (Cambridge, Mass.). 1992;3:374–378.CrossRefGoogle Scholar
  35. 35.
    Andersen V, Christensen J, Ernst A, et al. Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol. 2011;17:197–206.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Nunes T, Etchevers MJ, Merino O, et al. Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis. 2013;19:23–29.CrossRefPubMedGoogle Scholar
  37. 37.
    Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, Satsangi J. Does cigarette smoking influence the phenotype of Crohn’s disease? Analysis using the Montreal classification. Am J Gastroenterol. 2007;102:577–588.CrossRefPubMedGoogle Scholar
  38. 38.
    Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology. 1996;110:424–431.CrossRefPubMedGoogle Scholar
  39. 39.
    Domenech E, Carrion S, Garcia-Planella E, et al. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:971–975.CrossRefPubMedGoogle Scholar
  40. 40.
    Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn’s disease as defined by clinical variables. Dig Dis Sci. 2007;52:2897–2903.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Peiqi Wang
    • 1
  • Jun Hu
    • 2
    • 3
  • Shadi Ghadermarzi
    • 4
  • Ali Raza
    • 5
  • Douglas O’Connell
    • 6
  • Amy Xiao
    • 7
  • Faraz Ayyaz
    • 8
  • Min Zhi
    • 2
  • Yuanqi Zhang
    • 2
  • Nimisha K. Parekh
    • 6
  • Mark Lazarev
    • 9
  • Alyssa Parian
    • 9
  • Steven R. Brant
    • 10
  • Marshall Bedine
    • 9
  • Brindusa Truta
    • 9
  • Pinjin Hu
    • 2
  • Rupa Banerjee
    • 11
  • Susan M. Hutfless
    • 12
    • 13
    Email author
  1. 1.Department of SurgeryJohns Hopkins UniversityBaltimoreUSA
  2. 2.Department of GastroenterologyThe Sixth Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  3. 3.Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor DiseasesThe Sixth Affiliated HospitalGuangzhouChina
  4. 4.Department of Internal MedicineEast Carolina UniversityGreenvilleUSA
  5. 5.Department of Cardiology, Boston Children’s HospitalHarvard Medical SchoolBostonUSA
  6. 6.School of Medicine, Division of GastroenterologyUniversity of CaliforniaIrvineUSA
  7. 7.Department of Biomedical Engineering, Whiting School of EngineeringJohns Hopkins UniversityBaltimoreUSA
  8. 8.Services Institute of Medical SciencesLahorePakistan
  9. 9.Department of Medicine, Division of Gastroenterology and Hepatology, Meyerhoff Inflammatory Bowel Disease CenterJohns Hopkins UniversityBaltimoreUSA
  10. 10.Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers HealthRobert Wood Johnson Medical SchoolNew BrunswickUSA
  11. 11.Asian Institute of GastroenterologyHyderabadIndia
  12. 12.Division of Gastroenterology and Hepatology, Gastrointestinal Epidemiology Research CenterJohns Hopkins UniversityBaltimoreUSA
  13. 13.Department of EpidemiologyJohns Hopkins University Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations